CEO Robert Lisicki takes medical leave; COO Kim Davis appointed interim CEO effective Oct 10

Zura Bio Ltd

CEO Robert Lisicki informed Zura Bio of a medical leave of absence starting October 10, 2025.
Board appointed Kim Davis (COO, CLO, Corporate Secretary) as interim CEO effective October 10, 2025.
Davis will serve as interim CEO in addition to her current duties as COO, CLO, and Corporate Secretary.
No arrangement, transactions under Item 404(a), or family relationships disclosed related to appointment.

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-098546
form_type: 8-K
ticker: ZURA
cik: 0001855644
company_name: Zura Bio Ltd
filed_at: 2025-10-10T23:59:59+00:00
discovered_at: 2026-05-14T18:02:40.836246+00:00
generated_at: 2026-05-17T04:06:07.359954+00:00
sec_items: ["5.02"]
event_type: leadership
sentiment: neutral
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-098546
json_url: https://secwatch.observer/filing/0001104659-25-098546.json
markdown_url: https://secwatch.observer/filing/0001104659-25-098546.md
text_url: https://secwatch.observer/filing/0001104659-25-098546.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1855644/000110465925098546/0001104659-25-098546-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1855644/000110465925098546/tm2528470d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-098546

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.